weight loss drugs
Noom Adds $29 Oral Weight Loss Med Dubbed a “Miracle Drug”
Digital healthcare platform Noom is launching oral weight loss medication, beginning with FDA-approved Metformin.
Echelon Pushes into GLP-1 Space with ActiveMD
Echelon has been a fitness industry player since 2017—and now it’s leveling up with ActiveMD, offering customers access to weight loss drugs.
The Business of GLP-1s: Inside the New Weight Loss Drug Ecosystem
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Former Xponential CEO Anthony Geisler Talks Fitness Franchising, Rise of GLP-1s
Anthony Geisler addresses his departure from Xponential and analyzes the current fitness and wellness landscape in an exclusive interview.
GLP-1s Could Help Treat Alcohol Abuse, Study Shows
GLP-1 drugs are making headlines for their weight-loss powers, but they might also be effective in helping people kick alcohol dependency.
Ivim at Work Launches as GLP-1 Corporate Wellness Program
Increasing access to GLP-1 weight-loss drugs can be the ticket to employee productivity and retention, the corporate wellness platform
JP Morgan Targets Weight Loss Drugs With $500M Fund
JP Morgan Private Capital has raised over $500 million for a life sciences fund targeting private biotech companies and the booming weight-loss drug space.
How Body Scanning Tech Helps Fitness Brands Thrive in the GLP-1 Era
Advanced body scanning tech from brands like Evolt help GLP-1 users mitigate the risks of losing muscle mass while on weight-loss drugs.
Hims & Hers, Nestle Enter the GLP-1 Race
Hims & Hers will now provide access to compounded GLP-1s for eligible consumers at a discounted rate compared to brand-name prescriptions.
Can The Vitamin Shoppe Compete With Pure Telehealth Platforms?
The Vitamin Shoppe is launching a telehealth service, Whole Health Rx, which offers consumers access to GLP-1 drugs such as Ozempic.
